» Articles » PMID: 22839999

S-protected Thiolated Chitosan: Synthesis and in Vitro Characterization

Overview
Journal Carbohydr Polym
Specialty Biochemistry
Date 2012 Jul 31
PMID 22839999
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose of the present study was the generation and evaluation of novel thiolated chitosans, so-named S-protected thiolated chitosans as mucosal drug delivery systems. Stability of all conjugates concerning swelling and disintegration behavior as well as drug release was examined. Mucoadhesive properties were evaluated in vitro on intestinal mucosa. Different thiolated chitosans were generated displaying increasing amounts of attached free thiol groups on the polymer, whereby more than 50% of these thiol groups were linked with 6-mercaptonicotinamide. Based on the implementation of this hydrophobic residue, the swelling behavior was 2-fold decreased, whereas stability was essentially improved. Their mucoadhesive properties were 2- and 14-fold increased compared to corresponding thiolated and unmodified chitosans, respectively. Release studies out of matrix tablets comprising the novel conjugates revealed a controlled release of a model peptide. Accordingly, S-protected thiomers represent a promising type of mucoadhesive polymers for the development of various mucosal drug delivery systems.

Citing Articles

Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles.

Jarmila P, Veronika M, Peter M Int J Pharm X. 2024; 8:100281.

PMID: 39297017 PMC: 11408389. DOI: 10.1016/j.ijpx.2024.100281.


BBD Driven Fabrication of Hydroxyapatite Engineered Risedronate Loaded Thiolated Chitosan Nanoparticles and Their In Silico, In Vitro, and Ex Vivo Studies.

Saifi Z, Ralli T, Rizwanullah M, Alam M, Vohora D, Mir S Micromachines (Basel). 2023; 14(12).

PMID: 38138351 PMC: 10745864. DOI: 10.3390/mi14122182.


S-Protected Thiolated Chitosan versus Thiolated Chitosan as Cell Adhesive Biomaterials for Tissue Engineering.

Le-Vinh B, Steinbring C, Le N, Matuszczak B, Bernkop-Schnurch A ACS Appl Mater Interfaces. 2023; 15(34):40304-40316.

PMID: 37594415 PMC: 10472333. DOI: 10.1021/acsami.3c09337.


Development of Novel S-Protective Thiolated-Based Mucoadhesive Tablets for Repaglinide: Pharmacokinetic Study.

Alhakamy N, Raghavendra Naveen N, Gorityala S, Kurakula M, Hosny K, Safhi A Polymers (Basel). 2022; 14(17).

PMID: 36080604 PMC: 9460926. DOI: 10.3390/polym14173529.


Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms.

Abo El-Enin H, Mostafa R, Ahmed M, Naguib I, Abdelgawad M, Ghoneim M Pharmaceutics. 2022; 14(2).

PMID: 35214142 PMC: 8874718. DOI: 10.3390/pharmaceutics14020410.


References
1.
Mortazavi S, Smart J . Factors influencing gel-strengthening at the mucoadhesive-mucus interface. J Pharm Pharmacol. 1994; 46(2):86-90. DOI: 10.1111/j.2042-7158.1994.tb03746.x. View

2.
Barthelmes J, Perera G, Hombach J, Dunnhaupt S, Bernkop-Schnurch A . Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Int J Pharm. 2011; 416(1):339-45. DOI: 10.1016/j.ijpharm.2011.06.033. View

3.
Kafedjiiski K, Krauland A, Hoffer M, Bernkop-Schnurch A . Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials. 2004; 26(7):819-26. DOI: 10.1016/j.biomaterials.2004.03.011. View

4.
Bernkop-Schnurch A, Hornof M, Zoidl T . Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm. 2003; 260(2):229-37. DOI: 10.1016/s0378-5173(03)00271-0. View

5.
FORREST H, Walker J . Chemotherapeutic agents of the sulphone type; 2 : 5-disubstituted derivatives of pyridine. J Chem Soc. 1948; :1939-45. DOI: 10.1039/jr9480001939. View